EXPANDED ACCESS PROGRAM (EAP) FOR LENALIDOMIDE PLUS DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA

被引：0
|
作者：
Palumbo, A. [1 ]
Gay, F. [1 ]
Buda, G. [2 ]
Guglielmelli, T. [2 ]
Perrone, G. [2 ]
Corradini, P. [3 ]
Benedetti, F. [2 ]
Offidani, M. [2 ]
Rossi, D. [2 ]
Gozzetti, A. [2 ]
Catalano, L. [2 ]
Canepa, L. [4 ]
Di Raimondo, F. [5 ]
Patriarca, F. [2 ]
Petrucci, M. T. [2 ]
Di Renzo, N. [2 ]
Galli, M. [2 ]
Cavallo, F. [1 ]
Bringhen, S. [1 ]
Boccadoro, M. [1 ]
机构：
[1] AOU San Giovanni Battista, Turin, Italy
[2] Italian Multiple Myeloma Network, Gimema, Italy
[3] Ist Nazl Tumori, Div Ematol, I-20133 Milan, Italy
[4] Univ Genoa, Osp San Martino, Clin Ematol, Genoa, Italy
[5] Osped Ferrarotto, Cattedra Ematol, Catania, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0639
引用
下载
收藏
页码：257 / 257
页数：1
相关论文
共 50 条
  • [11] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone
    Junghoon Shin
    Je-Jung Lee
    Kihyun Kim
    Chang-Ki Min
    Jeong-Ok Lee
    Cheolwon Suh
    Jin Seok Kim
    Yoo Jin Lee
    Sung-Soo Yoon
    Jae-Cheol Jo
    Ho Sup Lee
    Soo-Mee Bang
    International Journal of Hematology, 2019, 109 : 79 - 90
  • [12] Erratum to: Lenalidomide plus dexamethasone treatment in Japanese patients with relapsed/refractory multiple myeloma
    Shinsuke Iida
    Takaaki Chou
    Shinichiro Okamoto
    Hirokazu Nagai
    Kiyohiko Hatake
    Hirokazu Murakami
    Toshiyuki Takagi
    Kazuyuki Shimizu
    Henry Lau
    Kenichi Takeshita
    Masaaki Takatoku
    Tomomitsu Hotta
    International Journal of Hematology, 2010, 92 (1) : 127 - 128
  • [13] Long-Term Use of Lenalidomide Plus Low-Dose Dexamethasone (Rd) in Chinese Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): MM-024 Expanded Access Program (EAP)
    Du, Xin
    Jin, Jie
    Cai, Zhen
    Chen, Fangping
    Zhou, Dao-bin
    Yu, Li
    Ke, Xiaoyan
    Li, Xiao
    Wu, Depei
    Meng, Fanyi
    DeMarco, Dena
    Zhang, Jingshan
    Mei, Jay
    Hou, Jian
    BLOOD, 2014, 124 (21)
  • [14] Lenalidomide plus dexamethasone demonstrates efficacy in the treatment of relapsed or refractory multiple myeloma
    不详
    FORMULARY, 2008, 43 (02) : 79 - 80
  • [15] Efficacy of lenalidomide plus dexamethasone in relapsed/refractory multiple myeloma: A systematic review
    Tandy, Fenia
    Hadisurya, Audrey
    Suciningtias, Marlyn
    Chrystelle, Celine
    Kurniawan, Andree
    ANNALS OF ONCOLOGY, 2022, 33 : S489 - S489
  • [16] Daratumumab plus lenalidomide and dexamethasone versus lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX
    Dimopoulos, Meletios A.
    San-Miguel, Jesus
    Belch, Andrew
    White, Darrell
    Benboubker, Lotfi
    Cook, Gordon
    Leiba, Merav
    Morton, James
    Ho, P. Joy
    Kim, Kihyun
    Takezako, Naoki
    Moreau, Philippe
    Kaufman, Jonathan L.
    Sutherland, Heather J.
    Lalancette, Marc
    Magen, Hila
    Iida, Shinsuke
    Kim, Jin Seok
    Prince, H. Miles
    Cochrane, Tara
    Oriol, Albert
    Bahlis, Nizar J.
    Chari, Ajai
    O'Rourke, Lisa
    Wu, Kaida
    Schecter, Jordan M.
    Casneuf, Tineke
    Chiu, Christopher
    Soong, David
    Sasser, A. Kate
    Khokhar, Nushmia Z.
    Avet-Loiseau, Herve
    Usmani, Saad Z.
    HAEMATOLOGICA, 2018, 103 (12) : 2088 - 2096
  • [17] Prolonged overall survival with lenalidomide plus dexamethasone compared with dexamethasone alone in patients with relapsed or refractory multiple myeloma
    Weber, Donna
    Knight, Robert
    Chen, Christine
    Spencer, Andrew
    Yu, Zhinuan
    Zeldis, Jerome
    Olesnyckyj, Marta
    Dimopoulos, Meletios
    BLOOD, 2007, 110 (11) : 128A - 128A
  • [18] CARFILZOMIB, LENALIDOMIDE AND DEXAMETHASONE IN JAPANESE PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
    Ri, M.
    Suzuki, K.
    Chou, T.
    Sugiura, I.
    Takezako, N.
    Sunami, K.
    Ishida, T.
    Izumi, T.
    Ozaki, S.
    Iida, S.
    HAEMATOLOGICA, 2016, 101 : 787 - 788
  • [19] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    Siegel, D. S.
    Richardson, P.
    Dimopoulos, M.
    Moreau, P.
    Mitsiades, C.
    Weber, D.
    Houp, J.
    Gause, C.
    Vuocolo, S.
    Eid, J.
    Graef, T.
    Anderson, K. C.
    BLOOD CANCER JOURNAL, 2014, 4 : e182 - e182
  • [20] Vorinostat in combination with lenalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma
    D S Siegel
    P Richardson
    M Dimopoulos
    P Moreau
    C Mitsiades
    D Weber
    J Houp
    C Gause
    S Vuocolo
    J Eid
    T Graef
    K C Anderson
    Blood Cancer Journal, 2014, 4 : e182 - e182
12345